cobalt health

Live MatureLargeHealthy

cobalt health Company Information

Share COBALT HEALTH

Company Number

04366596

Directors

Mark Callaway

Janet Ropner

View All

Shareholders

-

Group Structure

View All

Industry

Specialist medical practice activities

 +1

Registered Address

linton house clinic, thirlestaine road, cheltenham, gloucestershire, GL53 7AS

cobalt health Estimated Valuation

£20.9m

Pomanda estimates the enterprise value of COBALT HEALTH at £20.9m based on a Turnover of £25.4m and 0.82x industry multiple (adjusted for size and gross margin).

cobalt health Estimated Valuation

£5.9m

Pomanda estimates the enterprise value of COBALT HEALTH at £5.9m based on an EBITDA of £980.1k and a 5.99x industry multiple (adjusted for size and gross margin).

cobalt health Estimated Valuation

£73.1m

Pomanda estimates the enterprise value of COBALT HEALTH at £73.1m based on Net Assets of £31.9m and 2.3x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Cobalt Health Overview

Cobalt Health is a live company located in cheltenham, GL53 7AS with a Companies House number of 04366596. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in February 2002, it's largest shareholder is unknown. Cobalt Health is a mature, large sized company, Pomanda has estimated its turnover at £25.4m with healthy growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Cobalt Health Health Check

Pomanda's financial health check has awarded Cobalt Health a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 4 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating4.5out of 5
positive_score

6 Strong

positive_score

1 Regular

positive_score

4 Weak

size

Size

annual sales of £25.4m, make it larger than the average company (£604.9k)

£25.4m - Cobalt Health

£604.9k - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 5%, show it is growing at a slower rate (7.6%)

5% - Cobalt Health

7.6% - Industry AVG

production

Production

with a gross margin of 46.2%, this company has a comparable cost of product (46.2%)

46.2% - Cobalt Health

46.2% - Industry AVG

profitability

Profitability

an operating margin of -6.8% make it less profitable than the average company (10%)

-6.8% - Cobalt Health

10% - Industry AVG

employees

Employees

with 174 employees, this is above the industry average (15)

174 - Cobalt Health

15 - Industry AVG

paystructure

Pay Structure

on an average salary of £45.9k, the company has a higher pay structure (£28.4k)

£45.9k - Cobalt Health

£28.4k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £145.8k, this is more efficient (£58.5k)

£145.8k - Cobalt Health

£58.5k - Industry AVG

debtordays

Debtor Days

There is insufficient data available for this Key Performance Indicator!

- - Cobalt Health

- - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 57 days, this is slower than average (27 days)

57 days - Cobalt Health

27 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 1 days, this is less than average (12 days)

1 days - Cobalt Health

12 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 45 weeks, this is less cash available to meet short term requirements (101 weeks)

45 weeks - Cobalt Health

101 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 10.1%, this is a lower level of debt than the average (25.9%)

10.1% - Cobalt Health

25.9% - Industry AVG

COBALT HEALTH financials

EXPORTms excel logo

Cobalt Health's latest turnover from March 2024 is £25.4 million and the company has net assets of £31.9 million. According to their latest financial statements, Cobalt Health has 174 employees and maintains cash reserves of £3.1 million as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Turnover25,362,33026,842,87422,884,17821,674,56913,749,93711,785,63810,604,7149,839,7338,770,1988,200,7927,892,7526,423,5146,061,8625,220,3856,480,878
Other Income Or Grants
Cost Of Sales13,645,44314,444,88711,872,06211,926,3267,007,5206,053,2885,148,5014,376,0964,123,5693,760,4513,450,3922,688,4032,584,0502,283,5852,850,327
Gross Profit11,716,88712,397,98711,012,1169,748,2436,742,4175,732,3505,456,2135,463,6374,646,6294,440,3414,442,3603,735,1113,477,8122,936,8003,630,551
Admin Expenses13,450,28111,430,2797,391,2601,333,3575,590,7654,638,5414,231,0883,957,0963,507,0463,244,7313,115,3103,771,6043,074,4242,936,2691,596,643
Operating Profit-1,733,394967,7083,620,8568,414,8861,151,6521,093,8091,225,1251,506,5411,139,5831,195,6101,327,050-36,493403,3885312,033,908
Interest Payable
Interest Receivable
Pre-Tax Profit-1,562,630913,7942,931,7616,802,534934,772891,731999,7851,211,867926,228960,9321,036,403-21,274310,41413,0611,471,318
Tax
Profit After Tax-1,562,630913,7942,931,7616,802,534934,772891,731999,7851,211,867926,228960,9321,036,403-21,274310,41413,0611,471,318
Dividends Paid
Retained Profit-1,562,630913,7942,931,7616,802,534934,772891,731999,7851,211,867926,228960,9321,036,403-21,274310,41413,0611,471,318
Employee Costs7,988,8456,933,0095,264,0894,354,8263,869,7313,445,6243,165,2083,016,9492,729,7302,592,0942,242,8851,916,4791,735,736
Number Of Employees17416113111710295918473686047434542
EBITDA*980,0783,421,7735,662,08810,146,4592,458,3802,544,0302,818,2652,703,6582,255,5152,226,5142,753,6871,247,8531,618,5721,024,5982,874,306

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Tangible Assets24,165,48325,293,20622,730,79519,763,13017,039,59314,611,32014,570,19714,616,91012,480,94313,502,10911,724,86512,544,63012,332,32712,090,57611,533,344
Intangible Assets77,276104,082169,577189,491144,00367,061146,921153,215172,915
Investments & Other150,001150,001150,001150,001150,0011111,250,0011
Debtors (Due After 1 year)
Total Fixed Assets24,392,76025,547,28923,050,37320,102,62217,333,59714,678,38214,717,11914,770,12613,903,85913,502,11011,724,86512,544,63012,332,32712,090,57611,533,344
Stock & work in progress60,047
Trade Debtors131,117332,333139,7451,098,65320,72218,7882,143
Group Debtors360290
Misc Debtors4,717,0944,417,4773,984,5213,790,1252,466,9782,231,7371,762,4611,511,9961,691,261166,954897,657815,441650,987490,051701,019
Cash3,089,7644,729,4765,929,0716,146,3923,608,5901,166,001725,6212,945,4433,688,4513,592,5154,711,1372,859,8883,227,7693,208,2373,835,617
misc current assets3,204,5613,095,9103,045,1023,032,2652,050,8334,534,4054,002,1771,250,000
total current assets11,071,46612,242,86312,958,69412,968,7828,126,4018,063,2606,822,5925,847,1845,379,7124,858,1225,629,5163,694,1173,880,8993,698,6484,536,926
total assets35,464,22637,790,15236,009,06733,071,40425,459,99822,741,64221,539,71120,617,31019,283,57118,360,23217,354,38116,238,74716,213,22615,789,22416,070,270
Bank overdraft
Bank loan613,18380,16344,751
Trade Creditors 2,144,8142,309,1641,198,7221,345,5501,988,067517,557261,781331,283238,422259,697308,257196,242199,217185,515118,228
Group/Directors Accounts
other short term finances
hp & lease commitments150,727145,023139,534134,253
other current liabilities1,247,0841,087,8241,128,809810,315688,008374,934320,510328,392299,381280,995187,516220,300170,530198,144559,538
total current liabilities3,542,6254,155,1942,547,2282,334,8692,676,075892,491582,291659,675537,803540,692495,773416,542369,747383,659677,766
loans595,653662,576
hp & lease commitments52,219202,946347,968487,502
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities52,219202,946943,6211,150,078
total liabilities3,594,8444,358,1403,490,8493,484,9472,676,075892,491582,291659,675537,803540,692495,773416,542369,747383,659677,766
net assets31,869,38233,432,01232,518,21829,586,45722,783,92321,849,15120,957,42019,957,63518,745,76817,819,54016,858,60815,822,20515,843,47915,405,56515,392,504
total shareholders funds31,869,38233,432,01232,518,21829,586,45722,783,92321,849,15120,957,42019,957,63518,745,76817,819,54016,858,60815,822,20515,843,47915,405,56515,392,504
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Operating Activities
Operating Profit-1,733,394967,7083,620,8568,414,8861,151,6521,093,8091,225,1251,506,5411,139,5831,195,6101,327,050-36,493403,3885312,033,908
Depreciation2,647,9772,388,5701,974,0831,684,5611,261,4231,388,4521,537,9441,152,1581,115,9321,030,9041,426,6371,284,3461,215,1841,024,067840,398
Amortisation65,49565,49567,14947,01245,30561,76955,19644,959
Tax
Stock60,047
Debtors299,617432,956194,3961,323,147104,124268,060443,053-39,520425,654347,22884,150181,099162,719-210,898701,309
Creditors-164,3501,110,442-146,828-642,5171,470,510255,776-69,50292,861-21,275-48,560112,015-2,97513,70267,287118,228
Accruals and Deferred Income159,260-40,985318,494122,307313,07454,424-7,88229,01118,38693,479-32,78449,770-27,614-361,394559,538
Deferred Taxes & Provisions
Cash flow from operations615,3244,058,2745,639,3588,303,1024,137,8402,586,1702,297,8282,865,0501,826,9721,924,2052,748,7681,113,5491,441,941941,3892,850,763
Investing Activities
capital expenditure-1,429,575-1,446,946-3,313,384-267,681-2,762,148-606,872-1,496,833-1,329,435-1,581,299-1,771,809
Change in Investments150,000-1,250,0001,250,0001
cash flow from investments-150,000-1,429,575-1,446,946-2,063,384-1,517,681-2,762,149-606,872-1,496,833-1,329,435-1,581,299-1,771,809
Financing Activities
Bank loans-613,183533,02035,41244,751
Group/Directors Accounts
Other Short Term Loans
Long term loans-595,653-66,923662,576
Hire Purchase and Lease Commitments-145,023-139,533-134,253621,755
other long term liabilities
share issue127,50013,921,186
interest
cash flow from financing-758,206-202,166-165,7641,329,082127,50013,921,186
cash and cash equivalents
cash-1,639,712-1,199,595-217,3212,537,8022,442,589440,380-2,219,822-743,00895,936-1,118,6221,851,249-367,88119,532-627,3803,835,617
overdraft
change in cash-1,639,712-1,199,595-217,3212,537,8022,442,589440,380-2,219,822-743,00895,936-1,118,6221,851,249-367,88119,532-627,3803,835,617

cobalt health Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for cobalt health. Get real-time insights into cobalt health's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Cobalt Health Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for cobalt health by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other large companies, companies in GL53 area or any other competitors across 12 key performance metrics.

cobalt health Ownership

COBALT HEALTH group structure

Cobalt Health has 1 subsidiary company.

Ultimate parent company

COBALT HEALTH

04366596

1 subsidiary

COBALT HEALTH Shareholders

--

cobalt health directors

Cobalt Health currently has 10 directors. The longest serving directors include Dr Mark Callaway (Dec 2015) and Dr Janet Ropner (May 2019).

officercountryagestartendrole
Dr Mark CallawayEngland29 years Dec 2015- Director
Dr Janet Ropner78 years May 2019- Director
Dr Valerie Udale63 years Feb 2020- Director
Mrs Ruth Goddard60 years Feb 2020- Director
Miss Claire Morris57 years Jun 2022- Director
Mrs Pamela SissonsEngland62 years Jun 2022- Director
Dr Felicity Jenkins69 years Nov 2023- Director
Mr Matthew Jones55 years Nov 2023- Director
Mr Philip Leonard58 years Nov 2023- Director
Prof Gordon WilcockEngland79 years Jan 2024- Director

P&L

March 2024

turnover

25.4m

-6%

operating profit

-1.7m

0%

gross margin

46.2%

+0.02%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

31.9m

-0.05%

total assets

35.5m

-0.06%

cash

3.1m

-0.35%

net assets

Total assets minus all liabilities

cobalt health company details

company number

04366596

Type

Private Limited by guarantee without Share Capital Exempt from using Limited

industry

86220 - Specialist medical practice activities

86900 - Other human health activities

incorporation date

February 2002

age

23

incorporated

UK

ultimate parent company

None

accounts

Full Accounts

last accounts submitted

March 2024

previous names

cobalt unit appeal fund (January 2015)

accountant

-

auditor

CROWE UK LLP

address

linton house clinic, thirlestaine road, cheltenham, gloucestershire, GL53 7AS

Bank

NATIONAL WESTMINSTER BANK PLC

Legal Advisor

WILLANS LLP

cobalt health Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 1 charges/mortgages relating to cobalt health. Currently there are 1 open charges and 0 have been satisfied in the past.

cobalt health Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for COBALT HEALTH. This can take several minutes, an email will notify you when this has completed.

cobalt health Companies House Filings - See Documents

datedescriptionview/download